Pharmaceutical and veterinary preparations for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); biological preparations for medical purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); biochemical preparations for medical purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemical preparations for pharmaceutical purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); medical preparations of trace elements for human and animal use namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); ferments for use as pharmaceutical preparations for general health and wellbeing; biotechnological preparations for medical purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemical preparations for medicinal purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemical preparations for medical or veterinary purposes namely for the treatment of central nervous system diseases, cancer and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemical preparations for sanitary use for preventing pathogenic infections in humans and animals; pharmaceutical preparations for immunity adjustment namely immunomodulatory; vitamin preparations; vaccines for bacterial, fungal, viral and parasitic infections; dietary supplements for general health and wellbeing; therapeutic drugs and agents namely the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemico-pharmaceutical preparations namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); bacteriological preparations for medical and veterinary use namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x)